Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Squamous Cell Carcinoma of Head and Neck 8Oropharyngeal Neoplasms 7Cholangiocarcinoma 7Pancreatic Neoplasms 6Lung Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 4Mouth Neoplasms 4Laryngeal Neoplasms 4Gallbladder Neoplasms 4Carcinoma 4Sarcoma 3Hypopharyngeal Neoplasms 3Fallopian Tube Neoplasms 3Urethral Neoplasms 2Stomach Neoplasms 2Peritoneal Neoplasms 2Paranasal Sinus Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Mesothelioma, Malignant 2Klatskin Tumor 2Colorectal Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ureteral Neoplasms 1Testicular Neoplasms 1Stomatitis 1

Interventions

Pemetrexed 22Cisplatin 20Nivolumab 8Gemcitabine 7Carboplatin 7durvalumab 5Ipilimumab 5Bevacizumab 5pembrolizumab 4Radiotherapy, Intensity-Modulated 4tremelimumab 3niraparib 3Oxaliplatin 3Drug Therapy 3Cyclophosphamide 3Cerebral Decortication 3Blood Specimen Collection 3sargramostim 2Thoracoscopy 2Surveys and Questionnaires 2Sorafenib 2Radiosurgery 2Magnesium Sulfate 2Leucovorin 2Imatinib Mesylate 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2Dexamethasone 2tislelizumab 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mesothelioma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT04158141 2026-05-19

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

NRG Oncology

Phase 3 Terminated
16 enrolled 18 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡